John Restaino

Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR)

Benjamin L. Schooley, Matthew A. Taylor, P. Yarnold, 2020, EClinicalMedicine.

Caveat Medicus: Clinician experiences in publishing reports of serious oncology-associated adverse drug reactions

Benjamin L. Schooley, Matthew A. Taylor, J. Armitage, 2019, PloS one.

Systematic Approach to Pharmacovigilance beyond the Limits: The Southern Network on Adverse Reactions (SONAR) Projects

C. Bennett, O. Sartor, J. Bian, 2014 .

Davids versus Goliaths: Pharma and academia threats to individual scientists and clinicians

Benjamin L. Schooley, J. Mckoy, W. Hrushesky, 2022, The Journal of Scientific Practice and Integrity.

Key Elements in Adverse Drug Reactions Safety Signals: Application of Legal Strategies.

Brian K. Chen, J. Restaino, Elizabeth Tippett, 2018, Cancer treatment and research.